Open Closing in a 14 days
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
Descriptions
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026
Offer reference number: CM/TNS/25/5735
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)
Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)
Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
North West
South West
North East
East of England
Yorkshire and The Humber
South East
East Midlands
West Midlands
Ireland
Wales
Scotland
Northern Ireland
London
CPV Codes
33600000 - Pharmaceutical products
Keywords
medicinal drugs
prescription medicines
generic pharmaceuticals
active pharmaceutical ingredients
pharmaceutical compounds
Tender Lot Details
2 Tender Lots
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors
